Immune-mediated renal disorder

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 1 Phase I/II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Adarx Pharmaceuticals Inc. Commercial
    ADX-038
    2025-521752-26-00 2 countries 2026 n=7
    Recruiting

Phase I/II

1 trial
  • Arrowhead Pharmaceuticals Inc. Commercial
    ADS-011
    2023-506690-36-00 1 country 2024 n=5
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Adarx Pharmaceuticals Inc. Commercial 1 Phase II 1
Arrowhead Pharmaceuticals Inc. Commercial 1 Phase I/II 0
New trials by year
2024
1
2026
1
← All indication landscapes